Indicated for: cancer
Route of administration: oral
Substance: lomustine (antineoplastic agent)
ATC: L01AD02 (Antineoplastic and immunomodulating agents | Alkylating agents | Nitrosoureas)
Lomustine is a chemotherapy medication used to treat certain types of cancer, including brain tumors, Hodgkin's lymphoma, and other advanced cancers. It belongs to the class of alkylating agents and works by damaging the DNA of cancer cells, preventing them from multiplying.
The medication is taken orally, usually in capsule form, and the dosage is adjusted based on body weight and the type of cancer being treated. Treatment is carried out under the strict supervision of an oncologist.
Side effects may include nausea, vomiting, decreased blood cell counts, fatigue, and an increased risk of infections. It is important for patients to be regularly monitored to assess the effectiveness of the treatment and manage any adverse reactions.
Pregnant or breastfeeding women should not use lomustine, and patients must inform their doctor about any other medications or supplements they are taking.